Emcure partners with Roche to boost nephrology and transplant care in India
Emcure to distribute Roche's kidney transplant and anemia drugs in India
Emcure to distribute Roche's kidney transplant and anemia drugs in India
AINU is set to accelerate its expansion footprint, enhance operational capabilities
ANVIMO will be available in dosages of 240 mg and 480 mg
eGenesis is pioneering a genome engineering-based approach in the development of safe and effective transplantable organs to end the global organ shortage
Dr. Vinod Kumar Paul highlighted the huge gap between the demand for and supply of organs
Letermovir tablets, 240 mg and 480 mg had annual sales of USD 289.5 mn in the United States (IQVIA MAT Jan-24)
The first such initiative under the MoU will involve establishing a Centre of Excellence for Renal Sciences at the Tomo Riba Institute of Health & Medical Sciences (TRIHMS)
Apollo Transplant program is the first program in India to cross the landmark of 18500 kidney transplants, 4300 liver transplants and 500 pediatric liver transplants
Chinook Therapeutics is a clinical-stage biopharmaceutical company with two high-value, late-stage assets in development for IgA nephropathy (IgAN), a rare, progressive chronic kidney disease
Subscribe To Our Newsletter & Stay Updated